NO对心脏缺血再灌注损伤的影响及其在缺血预处理中的作用

目的:明确NO对心脏缺血再灌注(IR)损伤的影响及其在缺血预处理(IP)保护机制中的作用,同时观察NO对缺血再灌注凋亡的影响。方法:使用在体大鼠心脏缺血再灌注模型,实验共分为6组:IR组,IR+L-arg组,IR+L-NAME组,IP组,IP+L-arg组,IP+L-NAME组,观察分析心功能、梗塞面积、中性粒细胞(PMN)计数、心肌髓过氧化物酶(MPO)活性、TUNEL阳性细胞计数等指标。结果:L-arg,L-NAME均明显减轻了IR引起的PMN浸润和心肌细胞凋亡。缺血预处理前给予NO前体L-arg增加NO生成或使用L-NAME阻断NO生成对缺血预处理保护作用无明显影响。结论:缺血前组予L-arg增加内源性NO生成可对心肌缺血再灌注发挥保护作用;组予L-NAME可能通过减少再灌注其ONOO^-的生成而减轻心肌损伤和凋亡。

Role of nitric oxide in ischemia/reperfusion injury and ischemic preconditioning

AIM: To clarify the role of nitric oxide(NO) in ischemic preconditioning(IP) and its effects on apoptosis. METHODS: Seventy-two male Wistar rats were divided into the following six groups:ischemia/reperfusion (IR) group,IP group,IR+L-arg group,IP+L-arg group,IR+L-NAME group and IP+L-NAME group,The following changes were measured:cardiac hemodynamic parameters,infarct size,PMNs counting myocardial MPO activity and TUNEL staining.RESULTS: ①L-arg significantly attenuated ischemia/reperfusion-induced heart injury,reduced PMNs infiltration and cardiomyocyte apoptosis.②L-NAME also significantly reduced infarct size,PMNs infiltration and cardiomyocyte apoptosis compared with IR group,however,L-NAME aggravated ischemia/reperfusions-induced cardiac functional injury.③L-arg or L-NAME did not significantly alter the protective effect of ischemic preconditioning. CONCLUSION: Increased production of endogenous NO before prolonged ischemic period can protect hearts and inhibit apoptosis.L-NAME can inhibit iNOS activity and ONOO^- production in reperfusion period to protect heart.